source
- Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide makerBristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.BioPharma Dive · 9d ago↗ source
- Recon: BMS to construct AI supercomputer with Nividia; Tempus to acquire cancer diagnostic maker Personalis for $1.5BWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 9d ago↗ source
- Asia-Pacific Roundup: TGA seeks feedback on Australian regulations for digital mental health toolsAustralia’s Therapeutic Goods Administration (TGA) is holding a consultation to inform changes to the regulatory framework for digital mental health tools (DMHTs).